Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EBS NASDAQ:IMMR NASDAQ:INVE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEBSEmergent Biosolutions$9.02-1.2%$8.34$5.61▼$14.06$465.74M2.33859,574 shs821,065 shsIMMRImmersion$6.44+0.9%$6.07$5.25▼$8.15$213.16M1.03455,081 shs376,739 shsINVEIdentiv$3.94+0.3%$3.99$3.08▼$5.30$94.60M1.25137,542 shs103,129 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEBSEmergent Biosolutions+8.07%+13.57%+14.27%-16.67%+43.28%IMMRImmersion+1.75%+5.28%+4.76%+3.24%-12.36%INVEIdentiv-2.48%-0.25%-10.07%+24.76%+19.09%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEBSEmergent Biosolutions$9.02-1.2%$8.34$5.61▼$14.06$465.74M2.33859,574 shs821,065 shsIMMRImmersion$6.44+0.9%$6.07$5.25▼$8.15$213.16M1.03455,081 shs376,739 shsINVEIdentiv$3.94+0.3%$3.99$3.08▼$5.30$94.60M1.25137,542 shs103,129 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEBSEmergent Biosolutions+8.07%+13.57%+14.27%-16.67%+43.28%IMMRImmersion+1.75%+5.28%+4.76%+3.24%-12.36%INVEIdentiv-2.48%-0.25%-10.07%+24.76%+19.09%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEBSEmergent Biosolutions 2.00Hold$12.0033.05% UpsideIMMRImmersion 2.00Hold$13.50109.63% UpsideINVEIdentiv 2.50Moderate Buy$6.3360.74% UpsideCurrent Analyst Ratings BreakdownLatest INVE, IMMR, and EBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026INVEIdentiv Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $6.005/14/2026INVEIdentiv Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $7.005/11/2026EBSEmergent Biosolutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)5/8/2026IMMRImmersion Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/8/2026IMMRImmersion Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold4/27/2026EBSEmergent Biosolutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)4/24/2026IMMRImmersion Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)3/27/2026INVEIdentiv Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)3/9/2026EBSEmergent Biosolutions HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$15.00 ➝ $12.003/2/2026EBSEmergent Biosolutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)(Data available from 5/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEBSEmergent Biosolutions$742.90M0.63$3.90 per share2.31$10.13 per share0.89IMMRImmersion$1.56B0.14$4.08 per share1.58$17.25 per share0.37INVEIdentiv$21.48M4.40N/AN/A$5.71 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEBSEmergent Biosolutions$52.60M-$0.28N/AN/AN/A-1.27%10.76%4.22%8/5/2026 (Estimated)IMMRImmersion$64.28M$0.02322.0024.77N/A-0.97%-4.54%-1.97%7/8/2026 (Estimated)INVEIdentiv-$18M-$0.72N/AN/AN/A-70.52%-11.74%-11.04%8/6/2026 (Estimated)Latest INVE, IMMR, and EBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026INVEIdentiv-$0.14-$0.15-$0.01-$0.15$6.92 million$7.41 million5/1/2026Q2 2026IMMRImmersionN/A-$0.31N/A-$0.31N/A$518.49 million4/30/2026Q1 2026EBSEmergent Biosolutions-$0.25$0.21+$0.46$0.07$145.00 million$156.10 million4/14/2026Q1 2026IMMRImmersion$0.1460$0.36+$0.2140$0.36$425.00 million$650.17 million3/25/2026Q4 2025IMMRImmersion$0.1460-$0.03-$0.1760-$0.03$425.00 million$292.03 million3/12/2026Q4 2025INVEIdentiv-$0.17-$0.1565+$0.0135-$0.16$5.65 million$6.17 million3/11/2026Q4 2025IMMRImmersionN/A-$0.34N/A-$0.60N/A$284.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEBSEmergent BiosolutionsN/AN/AN/AN/AN/AIMMRImmersion$0.304.66%N/A1,500.00%N/AINVEIdentivN/AN/AN/AN/AN/ALatest INVE, IMMR, and EBS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/27/2026IMMRImmersionquarterly$0.07504.57%4/20/20264/20/20265/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEBSEmergent Biosolutions1.104.292.08IMMRImmersion0.251.831.16INVEIdentivN/A14.8713.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEBSEmergent Biosolutions78.40%IMMRImmersion60.57%INVEIdentiv65.16%Insider OwnershipCompanyInsider OwnershipEBSEmergent Biosolutions6.00%IMMRImmersion12.00%INVEIdentiv3.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEBSEmergent Biosolutions2,42051.64 million48.55 millionOptionableIMMRImmersion2033.10 million29.13 millionOptionableINVEIdentiv33024.01 million23.14 millionOptionableINVE, IMMR, and EBS HeadlinesRecent News About These CompaniesIdentiv (NASDAQ:INVE) Stock Passes Above 200-Day Moving Average - Should You Sell?May 22, 2026 | americanbankingnews.comIdentiv Inc Stock GuidanceMay 19, 2026 | benzinga.comIdentiv Inc (INVE) Q1 2026 Earnings Call Highlights: Surpassing Sales Guidance and Strategic ...May 15, 2026 | finance.yahoo.comIdentiv (INVE) Q1 2026 Earnings TranscriptMay 15, 2026 | fool.comIdentiv Q1 Earnings Call HighlightsMay 13, 2026 | marketbeat.comIdentiv, Inc. (INVE) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comIdentiv, Inc. (INVE) Reports Q1 Loss, Tops Revenue EstimatesMay 13, 2026 | zacks.comIdentiv Reports First Quarter 2026 Financial Results, Exceeds Q1 GuidanceMay 13, 2026 | prnewswire.comIdentiv (NASDAQ:INVE) Stock Crosses Above 200 Day Moving Average - What's Next?May 7, 2026 | marketbeat.comIdentiv Sets First Quarter 2026 Earnings Call for Wednesday, May 13, 2026, at 5:00 PM EDTApril 29, 2026 | prnewswire.comIdentiv (INVE) Projected to Post Quarterly Earnings on WednesdayApril 29, 2026 | marketbeat.comIdentiv Expands ID-Safe NFC Tag Portfolio to Enable Secure Product Authentication, Tamper Detection, and TraceabilityApril 20, 2026 | prnewswire.comIs Identiv (INVE) Outperforming Other Computer and Technology Stocks This Year?March 26, 2026 | zacks.com3 Computer Peripheral Equipment Stocks to Watch in a Thriving IndustryMarch 25, 2026 | zacks.comIdentiv (INVE) Q4 2025 Earnings Call TranscriptMarch 17, 2026 | fool.comIdentiv Inc (INVE) Q4 2025 Earnings Call Highlights: Revenue Surpasses Expectations Amid ...March 14, 2026 | finance.yahoo.comIdentiv outlines 26%–35% Q1 2026 sales growth target through BLE smart label expansionMarch 13, 2026 | seekingalpha.comIdentiv, Inc. (INVE) Q4 2025 Earnings Call TranscriptMarch 12, 2026 | seekingalpha.comIdentiv, Inc. (INVE) Reports Q4 Loss, Tops Revenue EstimatesMarch 12, 2026 | zacks.comIdentiv Reports Fourth Quarter and Fiscal Year 2025 Financial Results, Exceeds Q4 Guidance and Signs Multi-Year Supply AgreementMarch 12, 2026 | prnewswire.comIdentiv Announces Exclusive Agreement to Develop and Supply BLE Smart Labels, Advancing Its Perform, Accelerate, and Transform Growth StrategyMarch 10, 2026 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026SpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026Robinhood, SoFi, and Webull Are Telling Very Different StoriesBy Peter Frank | May 17, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026INVE, IMMR, and EBS Company DescriptionsEmergent Biosolutions NYSE:EBS$9.02 -0.11 (-1.22%) Closing price 03:59 PM EasternExtended Trading$9.09 +0.07 (+0.81%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.Immersion NASDAQ:IMMR$6.44 +0.06 (+0.94%) Closing price 04:00 PM EasternExtended Trading$6.44 -0.01 (-0.08%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Immersion Corporation, together with its subsidiaries, engages in the creation, design, development, and licensing of haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It serves markets, including mobility, gaming, automotive, virtual and augmented reality, and wearables, as well as residential, commercial, and industrial Internet of Things. The company was incorporated in 1993 and is headquartered in Aventura, Florida.Identiv NASDAQ:INVE$3.94 +0.01 (+0.25%) Closing price 04:00 PM EasternExtended Trading$3.92 -0.02 (-0.38%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Identiv, Inc., a security technology company, that provides secure identification and physical security solutions that secure things, data, and physical places worldwide. It operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, and apartment buildings. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak Amazon's Alexa for Shopping Strengthens an Already Strong Bull Case TeraWulf Bets on Power Infrastructure to Lead AI Build-Out Zscaler Stock Drops 30%: Why the Dip Is a Buy Opportunity Shake Shack Insiders Buy as SHAK Stock Faces More Pressure Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest Move Record Revenue, Rising Dividends—So Why Aren't Analysts Saying Buy? Qualcomm's TikTok AI Chip Deal Rewrites the Rules Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
